Characteristics of 28 eligible patients
| Characteristics . | No. of patients . |
|---|---|
| Sex | |
| Male | 20 |
| Female | 8 |
| Histologic subtype | |
| Nodular sclerosis | 21 |
| Mixed cellularity | 6 |
| Lymphocyte predominant | 1 |
| Ann Arbor clinical stage | |
| I | 1 |
| II | 9 |
| III | 7 |
| IV | 2 |
| Relapse | 9 |
| B symptoms | |
| Yes | 14 |
| No | 14 |
| Treatment | |
| Chemotherapy alone | 11 |
| Radiotherapy alone | 1 |
| Combined therapy | 8 |
| Salvage chemotherapy without PBSCT | 6 |
| Salvage chemotherapy with PBSCT | 2 |
| Prior mediastinal irradiation | |
| Yes | 18 |
| No | 10 |
| Characteristics . | No. of patients . |
|---|---|
| Sex | |
| Male | 20 |
| Female | 8 |
| Histologic subtype | |
| Nodular sclerosis | 21 |
| Mixed cellularity | 6 |
| Lymphocyte predominant | 1 |
| Ann Arbor clinical stage | |
| I | 1 |
| II | 9 |
| III | 7 |
| IV | 2 |
| Relapse | 9 |
| B symptoms | |
| Yes | 14 |
| No | 14 |
| Treatment | |
| Chemotherapy alone | 11 |
| Radiotherapy alone | 1 |
| Combined therapy | 8 |
| Salvage chemotherapy without PBSCT | 6 |
| Salvage chemotherapy with PBSCT | 2 |
| Prior mediastinal irradiation | |
| Yes | 18 |
| No | 10 |
The patients ranged in age from 18-76 years, with a median age of 36.